©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6909-6921
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6909
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6909
Table 1 Immunologic responses and directed therapies in alcoholic hepatitis
| Cytokines | Mechanism | Mediators | Treatment |
| Cytokines | |||
| TNFα | Via TNFR1 signaling in hepatocytes and Kupffer cells (KC) | Apoptosis, necrosis, KC production of cytokines, potential cytoprotective effect | Glucocorticoids; Pentoxifylline; Infliximab |
| IL-6, 8 | Lymphocyte and neutrophil activation, release of acute phase reactants | Inflammation, fibrosis | Glucocorticoids |
| Antigenic adduct | Oxidation of ethanol, binding to proteins forming antigenic adducts | Adaptive immunity | Glucocorticoids |
| Chemokines | Attract leukocytes and increase adhesion molecules | Inflammation | Glucocorticoids |
| Oxidative Injury | |||
| S-adenosyl-methionine (SAMe) | Precursor for glutathione, defense mechanism against oxidative stress, increase methylation | Protective role of SAMe | SAMe |
| Hypoxia/ischemic injury | Hypermetabolic state | Insufficient oxygen | Propylthiouracil |
- Citation: Rongey C, Kaplowitz N. Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol 2006; 12(43): 6909-6921
- URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6909.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i43.6909